Coherus Oncology Statistics Share Statistics Coherus Oncology has 116.23M
shares outstanding. The number of shares has increased by 0.63%
in one year.
Shares Outstanding 116.23M Shares Change (YoY) 0.63% Shares Change (QoQ) 0.03% Owned by Institutions (%) 53.58% Shares Floating 111.19M Failed to Deliver (FTD) Shares 40,746 FTD / Avg. Volume 2.9%
Short Selling Information The latest short interest is 31.87M, so 27.42% of the outstanding
shares have been sold short.
Short Interest 31.87M Short % of Shares Out 27.42% Short % of Float 28.51% Short Ratio (days to cover) 27.18
Valuation Ratios The PE ratio is 5.55 and the forward
PE ratio is -1.67.
Coherus Oncology's PEG ratio is
-0.05.
PE Ratio 5.55 Forward PE -1.67 PS Ratio 0.59 Forward PS 1.8 PB Ratio -1.2 P/FCF Ratio -7.73 PEG Ratio -0.05
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Coherus Oncology.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.21,
with a Debt / Equity ratio of -2.04.
Current Ratio 1.21 Quick Ratio 0.96 Debt / Equity -2.04 Debt / EBITDA 4.43 Debt / FCF -13.2 Interest Coverage -4.11
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $1.17M Profits Per Employee $125.03K Employee Count 228 Asset Turnover 0.6 Inventory Turnover 1.68
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 42.86% in the
last 52 weeks. The beta is 0.89, so Coherus Oncology's
price volatility has been higher than the market average.
Beta 0.89 52-Week Price Change 42.86% 50-Day Moving Average 1.15 200-Day Moving Average 1.08 Relative Strength Index (RSI) 62.15 Average Volume (20 Days) 1,404,856
Income Statement In the last 12 months, Coherus Oncology had revenue of 266.96M
and earned 28.51M
in profits. Earnings per share was 0.25.
Revenue 266.96M Gross Profit 149.41M Operating Income -111.67M Net Income 28.51M EBITDA 60.94M EBIT 55.66M Earnings Per Share (EPS) 0.25
Full Income Statement Balance Sheet The company has 125.99M in cash and 269.9M in
debt, giving a net cash position of -143.92M.
Cash & Cash Equivalents 125.99M Total Debt 269.9M Net Cash -143.92M Retained Earnings -1.55B Total Assets 439.46M Working Capital 116.58M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -20.44M
and capital expenditures 0, giving a free cash flow of -20.44M.
Operating Cash Flow -20.44M Capital Expenditures n/a Free Cash Flow -20.44M FCF Per Share -0.18
Full Cash Flow Statement Margins Gross margin is 55.97%, with operating and profit margins of -41.83% and 10.68%.
Gross Margin 55.97% Operating Margin -41.83% Pretax Margin 10.68% Profit Margin 10.68% EBITDA Margin 22.83% EBIT Margin -41.83% FCF Margin -7.66%
